risedronate sodium (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the risedronate sodium drug offered from Actavis Pharma, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | risedronate sodium |
| SUBSTANCE NAME: | RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2014-06-11 |
| END MARKETING DATE: | 0000-00-00 |
risedronate sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | risedronate sodium from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 129; 21(mg/1; mg/1) |
| START MARKETING DATE: | 2014-06-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-2044_7a248a22-542a-4581-8b00-1f87a2febea5 |
| PRODUCT NDC: | 0591-2044 |
| APPLICATION NUMBER: | NDA020835 |
Other RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
